Questions & Answers

By 2026, AI has moved from a passive decision-support tool to an active diagnostic partner.

• Autonomous Troubleshooting: New analyzers feature AI agents that monitor internal sensors in real-time, performing self-calibrations and predicting mechanical failures before they interrupt testing.

• Smart Triaging: AI models now automatically flag "unsuitable" samples (e.g., detecting minor hemolysis or lipemia) at the pre-analytical stage, preventing the generation of inaccurate results.

• Diagnostic Collaboration: AI systems no longer just report numbers; they provide "clinical context" by correlating chemistry results with a patient's historical data and EHR, highlighting critical trends for the lab director.